Sensus Healthcare, Inc. Stock price
Equities
SRTS
US81728J1097
Advanced Medical Equipment & Technology
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
3.8 USD | -3.06% | -0.26% | +61.02% |
Financials (USD)
Sales 2024 * | 26.63M | Sales 2025 * | 32.48M | Capitalization | 62.3M |
---|---|---|---|---|---|
Net income 2024 * | - | Net income 2025 * | 3M | EV / Sales 2024 * | 2.34 x |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | 1.92 x |
P/E ratio 2024 * |
127
x | P/E ratio 2025 * |
21.1
x | Employees | 35 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 76.13% |
Latest transcript on Sensus Healthcare, Inc.
1 day | -3.06% | ||
1 week | -0.26% | ||
Current month | -7.32% | ||
1 month | -15.37% | ||
3 months | +58.33% | ||
6 months | +43.40% | ||
Current year | +61.02% |
Managers | Title | Age | Since |
---|---|---|---|
Richard Golin
FOU | Founder | 71 | 10-05-06 |
Joseph Sardano
CEO | Chief Executive Officer | 71 | 10-05-06 |
Javier Rampolla
DFI | Director of Finance/CFO | 52 | 14-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Joseph Sardano
CEO | Chief Executive Officer | 71 | 10-05-06 |
Anthony Petrelli
BRD | Director/Board Member | 71 | 16-07-20 |
John Heinrich
BRD | Director/Board Member | 77 | 12-01-31 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.15% | 29 M€ | +0.33% | ||
0.08% | 26 M€ | +0.78% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-03-28 | 3.8 | -3.06% | 53,111 |
24-03-27 | 3.92 | -1.75% | 46,076 |
24-03-26 | 3.99 | +6.12% | 174,573 |
24-03-25 | 3.76 | -0.27% | 104,085 |
24-03-22 | 3.77 | -1.05% | 144,645 |
Delayed Quote Nasdaq, March 28, 2024 at 04:30 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+61.02% | 62.3M | |
-34.95% | 3.2B | |
+12.43% | 1.78B | |
-0.43% | 1.66B | |
+36.05% | 1.37B | |
-3.90% | 1.11B | |
-19.15% | 927M | |
-6.11% | 732M | |
-11.71% | 735M | |
+12.74% | 534M |